These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1594122)

  • 21. Renal transplantation in children.
    Topor MA
    J Am Assoc Nephrol Nurses Tech; 1981 Feb; 8(1):14-8. PubMed ID: 7009699
    [No Abstract]   [Full Text] [Related]  

  • 22. One-year transplantation activities in our center.
    Haberal M; Bilgin N; Velidedeoğlu E; Cuhadaroğlu S; Arslan G; Büyükpamukçu N; Simşek H; Karamehmetoğlu M; Telatar H
    Transplant Proc; 1993 Dec; 25(6):3149-50. PubMed ID: 8266494
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract]   [Full Text] [Related]  

  • 24. Kidney transplantation in Kermanshah, Iran: a 5-year experience.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2765-6. PubMed ID: 7482905
    [No Abstract]   [Full Text] [Related]  

  • 25. [Present status and perspectives of kidney transplantation].
    May G
    Z Gesamte Inn Med; 1986 May; 41(10):294-7. PubMed ID: 3529663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
    Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
    Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

  • 28. Kidney transplantation activities in Turkey.
    Haberal M; Karakayali H; Bilgin N; Arslan G; Büyükpamukçu N; Telatar H; Karamehmetoğlu M; Moray G
    Transplant Proc; 1996 Feb; 28(1):408-9. PubMed ID: 8644294
    [No Abstract]   [Full Text] [Related]  

  • 29. [15 years of renal transplantation under conventional immunosuppressive treatment].
    Launois B; Campion JP; Bardaxoglou E; Le Pogamp P; Tron de Bouchony E; Busson M; Prevost P; Fauchet R; Chevet D; Cartier F
    Chirurgie; 1988; 114(4):273-9. PubMed ID: 3069371
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term follow-up of renal transplants.
    Casciani CU; Tisone G; Baroni B; Elli M; Pisani F
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2174-5. PubMed ID: 2652700
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience using an immunosuppressive agent sandimmun (cyclosporin A) in kidney transplantation in the clinic].
    Belorusov OS; Goriaĭnov VA; Egorova IA
    Khirurgiia (Mosk); 1986 Mar; (3):72-6. PubMed ID: 3517470
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcome of renal transplants from pediatric donors <5 yr of age.
    El-Sabrout R; Buch K
    Clin Transplant; 2005 Jun; 19(3):316-20. PubMed ID: 15877791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early experience with cyclosporine in renal transplantation.
    Garvin PJ; Carney K; Castaneda M; Codd JE
    Mo Med; 1986 Mar; 83(3):154-8. PubMed ID: 3333817
    [No Abstract]   [Full Text] [Related]  

  • 34. Organization and results of kidney transplant activity in Italy during 1995-99.
    Venettoni S; Scuderi G; Mattucci DA; Diciaccio P; Quinteri F; Pugliese O; Chistolini P; Frustagli G; Macellari V; Costa AN
    Clin Transpl; 2000; ():368-70. PubMed ID: 11512339
    [No Abstract]   [Full Text] [Related]  

  • 35. Related donor kidney transplantation is the best form of treatment for uremia.
    Groth CG; Fehrman I; Ringdén O; Lundgren G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
    [No Abstract]   [Full Text] [Related]  

  • 36. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of double-filtration plasmapheresis on living related donor renal transplantation in presensitized recipients.
    Miura S; Okazaki H; Sato T; Amada N; Terashima T
    Transplant Proc; 1995 Feb; 27(1):1040-1. PubMed ID: 7878794
    [No Abstract]   [Full Text] [Related]  

  • 38. [Malignant neoplasms arising "de novo" after a kidney transplant. Our experience and a review of the literature].
    Tommasi GV; Arcuri V; Fontana I; Barabino M; Vassallo S; Casolino V; Valente U
    G Chir; 1994; 15(1-2):11-4. PubMed ID: 8018469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of acute rejection before kidney transplantation treated with donor specific transfusion plus azathioprine.
    Aikawa A; Tashiro M; Arai K; Ohara T; Iwashita Y; Kimura I; Hirata K; Hasegawa A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1839-41. PubMed ID: 2523596
    [No Abstract]   [Full Text] [Related]  

  • 40. Pediatric cadaveric kidneys in recipients treated with cyclosporine.
    Smith AY; Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):215-21. PubMed ID: 3291246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.